Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 294, Issue 2, 2002, Pages 384-394

  Duan, Renqin ^a   Xie, Wen ^a   Li, Xiangrong ^a   McDougal, Andrew ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

C fos; ER ; Estrogen; PI3 K; SRF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ESTRADIOL; ESTROGEN; FULVESTRANT; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; SERUM RESPONSE FACTOR; WORTMANNIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BREAST NEOPLASMS; CELL DIVISION; CHROMONES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ESTRADIOL; ETS-DOMAIN PROTEIN ELK-1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GROWTH SUBSTANCES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036290519     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00499-0     Document Type: Article

References (50)

1. The nuclear receptor superfamily: The second decade
2. Nuclear receptors in Sicily: All in the famiglia
3. Orchestrated response: A symphony of transcription factors for gene control
4. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
5. Functional synergy between the transcription factor Sp1 and the estrogen receptor
6. Ligand-, cell- and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements
7. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway
8. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
9. Ligand-independent activation of steroid hormone receptors
10. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
11. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
12. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation
13. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
14. Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter
15. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
16. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
17. Estrogen receptor α rapidly activates the IGF-1 receptor pathway
18. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
19. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1
20. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF
21. Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells
22. SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation
23. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
24. Control of human breast cancer by estrogen, growth factors, and oncogenes
25. Growth factors in breast cancer
26. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
27. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: Modulation of hormone-induced cell cycle enzymes
28. The fos oncogene
29. Journey to the surface of the cell: Fos regulation and the SRE
30. AP-1 function and regulation
31. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells
32. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells
33. Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells
34. Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells
35. Unregulated expression of c-Jun and c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer-derived cells
36. Estrogen regulation of proto-oncogenes coding for nuclear proteins
37. 17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation
38. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
39. The SRE: A growth factor responsive transcriptional regulator
40. Ternary complex factors: Growth factor regulated transcriptional activators
41. The JAK-STAT pathway: Summary of initial studies and recent advances
42. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
43. Integration of MAP kinase signal transduction pathways at the serum response element
44. Regulation of transcription by MAP kinase cascades
45. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a
46. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components
47. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: A new model for anti-estrogen resistance
48. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells
49. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
50. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src